Non-transplant surgical therapy options of heart failure

Area of Science:

• Cardiology
• Cardiovascular Surgery

Background:

• Congestive heart failure (CHF) is a significant cause of cardiovascular morbidity and mortality, with a 5-year mortality rate of 50%.
• The economic burden of CHF is substantial, driven by increased hospitalizations, advanced device implantation, and end-of-life care.
• CHF progression involves detrimental left ventricular remodeling, necessitating strategies to halt or reverse these changes.

Purpose of the Study:

• To provide an overview of non-transplant surgical management options for congestive heart failure.
• To highlight advancements in therapies and devices for managing CHF.
• To discuss strategies aimed at stopping or reversing left ventricular remodeling in heart failure.

Main Methods:

• Review of current literature on surgical interventions for CHF.
• Analysis of advancements in mechanical circulatory support, including left ventricular assist devices (LVADs) and total artificial hearts.
• Discussion of established and novel therapeutic strategies for heart failure management.

Main Results:

• Medical management, mechanical circulatory support, cardiac resynchronization therapy, and biventricular pacemakers are established treatments.
• Mechanical support devices like LVADs have significantly reduced mortality in patients awaiting transplantation.
• Non-transplant surgical options offer viable alternatives for managing CHF progression.

Conclusions:

• The management of CHF has evolved significantly with new therapies and assist devices.
• Non-transplant surgical options play a crucial role in improving outcomes for CHF patients.
• Continued innovation in surgical and device-based therapies is essential for addressing CHF mortality and morbidity.